In May 2026, surgeons at the Georgetown Public Hospital Corporation completed the first robotic trans-abdominal pre-peritoneal surgery performed in the English-speaking Caribbean. The procedure, a hernia repair, placed Guyana ahead of far wealthier neighbours in adopting a technology that remains the global standard for many operations yet has largely bypassed low- and middle-income countries because of its cost and infrastructure demands.

The patient was a 34-year-old man with an uncomplicated right inguinal hernia. The lead surgeon worked from a digital command console, directing robotic arms to place a synthetic mesh and repair the defect. Recovery was swift. The patient was walking and eating within a day, discharged inside 24 hours, and showed no complications at his two-week review.

Central to the operation was the SSI Mantra 3, a robotic surgical system developed in India. It has four modular arms, 3D high-definition monitors, and ergonomic controls that filter out hand tremors during fine manipulation. Its most significant feature for Guyana, however, was its price. The system costs roughly 35 per cent of what the dominant Western platforms charge, a difference that made the investment viable for a health system operating under tight constraints.

The May procedure was not an isolated leap but the product of two decades of gradual progress. Guyana performed its first laparoscopic cholecystectomy in 2002, beginning the country's move toward minimally invasive surgery. The laparoscopic TAPP technique reached the wider Caribbean region in 2005, and Guyanese surgeons began performing it locally by 2014. Each stage built the clinical experience that made the 2026 robotic procedure possible.

Guyana's success also stands in contrast to a stalled attempt in Trinidad and Tobago. In 2021, that country brought in a robotic camera arm, but interest faded when sustained leadership support failed to materialise. Guyana's team avoided the same fate by securing direct backing from the President and the Minister of Health, support that translated into funding and infrastructure rather than remaining symbolic.

Preparation for the operation was deliberately broad. A multidisciplinary team of Guyanese medical professionals travelled to India for two weeks of simulator work and live-case training, spanning several surgical specialties rather than a single department. That range has already paid off. Since the initial hernia repair, GPHC has used the robot for a variety of general, urologic, and gynaecological procedures, including gallbladder removals and gastric bypasses.

The system's data management functions are also expected to support a national robotic surgery registry, which the hospital intends to use to track outcomes and refine protocols as the programme expands.

Surgeons involved in the project have described their approach as a framework that other Caribbean nations could follow. It rests on four elements: leadership willing to secure funding and make public commitments, early engagement of local surgeons to build support for the transition, training across specialties to keep the machine in regular use and justify its cost, and procurement decisions that favour effective but affordable platforms over established market leaders.

Whether that framework travels well beyond Guyana remains to be tested. Robotic surgery programmes elsewhere in the region have faltered for want of the political continuity that Guyana managed to secure, and equipment costs, even discounted, still represent a substantial commitment for smaller health budgets. What the Georgetown case demonstrates is that the combination of low-cost hardware and sustained institutional backing can close a gap that has persisted in Caribbean healthcare for years. Whether other governments can replicate both halves of that equation, rather than one alone, will determine how far the model spreads.